Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
MAR heads into its November 2 earnings report with options traders more cautious than they have been all year, even as the stock sits on an 11% monthly gain.
The sharpest signal this week is in the options market. The put/call ratio has climbed to 0.9966, near its 52-week high of 1.0155 hit just one day earlier, and running well above its 20-day average of 0.865. At 1.69 standard deviations above that mean, the reading points to the heaviest demand for downside protection MAR has seen in the past twelve months. The timing matters: with earnings 23 days away, the defensive options positioning may reflect uncertainty rather than conviction about direction. The stock itself has been firm, up 1.9% on the week and 11.3% over the past month to close at $365.88, but that rally appears to have made some traders more alert to the downside than eager to chase further gains.
The lending market tells a completely different story. Short interest at 2.5% of the free float is low by any standard, and the borrow pool is essentially open. Availability is running above 5,000%, meaning there are more than fifty shares available to borrow for every one currently shorted. Cost to borrow is 0.45%, down 7% on the week, confirming there is no pressure in the lending market. Short interest has drifted down roughly 1.3% over the week, continuing a gradual retreat from late-September levels, when shorts had briefly built to around 7 million shares before unwinding. None of this resembles a stock with a meaningful short thesis behind it.
The Street is positioned with a cautious tilt, though not uniformly bearish. The most recent analyst action, a target raise to $360 from Truist in early September, came with a Hold rating, hardly a ringing endorsement at current prices. Around the same time, UBS cut its target from $412 to $395 while staying Neutral, and Wells Fargo trimmed from $449 to $425 even while keeping an Overweight. The mean price target across covering analysts is $380.80, offering only modest upside from the current level. The bull case rests on Marriott's asset-light model, 1.8 million rooms across roughly 30 brands, and its strong first quarter where EBITDA grew 15% year-on-year and global RevPAR rose 4.2%. The bear case is straightforward: 61% of rooms are in North America, 99% are managed or franchised, and a cyclical downturn hits fee revenue fast. The PE multiple has expanded to 28.1 times over the past thirty days, adding two full points, and EV/EBITDA is at 17.5 times. Both are moving in the direction of valuation stretch. Factor scores underline the tension: the dividend score ranks in the 99th percentile, but EV/EBIT sits in only the 21st.
Family ownership remains the dominant structural feature of MAR's register. J.W. Marriott Jr. filed a Schedule 13D in January disclosing an 11.4% stake. ORTEX records a live activist flag on that filing, though a 13D from a family founder is categorically different from a third-party activist. The disclosure caveat applies: the stake is as last reported, and holders who drop below 5% are not obliged to file again. On the open-market side, three family-connected insiders each sold 3,500 shares at roughly $352 on September 25, transactions totalling around $1.2 million apiece with no 10b5-1 plan declared. The timing, at a price below the current level but before the recent leg higher, reduces the significance of those sales somewhat. Peer performance on the week was broadly positive: HLT gained 2.3%, CHH rose 3.1%, and WH added 3.2%, with MAR's 1.9% advance a touch softer than the group average.
The last two earnings prints have been rough for the stock. The August 2026 quarter triggered a 7.4% one-day fall and a 6.5% decline over the following five days. The print before that produced a 2% single-day drop. With the November 2 release now the focal point, the degree to which option buyers are already paying for protection sets up the earnings reaction as the clearest thing to watch.
See the live data behind this article on ORTEX.
Open MAR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
